Common Contracts
44 similar Employment Agreement contracts by Celldex Therapeutics, Inc.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 1, 2021 (the “Effective Date”), between Diane Young, MD (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on July 1, 2021 (the “Effective Date”), between Sarah Cavanaugh (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 1, 2021 (the “Effective Date”), between Freddy Jimenez (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on July 1, 2021 (the “Effective Date”), between Ronald A. Pepin, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on July 1, 2021 (the “Effective Date”), between Tibor Keler, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on July 1, 2021 (the “Effective Date”), between Richard Wright, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 1, 2021 (the “Effective Date”), between Sam Martin (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 1, 2021 (the “Effective Date”), between Margo Heath-Chiozzi, M.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on July 1, 2021 (the “Effective Date”), between Anthony S. Marucci (the “Executive”) and CELLDEXTHERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 1st, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on July 1, 2021 (the “Effective Date”), between Elizabeth Crowley (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 4th, 2021 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of January 1, 2021 (the “Effective Date”), between Freddy Jimenez (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 24th, 2019 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 8, 2019 (the “Effective Date”), between Diane Young, MD (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Richard Wright, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Tibor Keler, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Elizabeth Crowley (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Sarah Cavanaugh (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Anthony S. Marucci (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 1, 2018 (the “Effective Date”), between Ronald A. Pepin, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of January 1, 2018 (the “Effective Date”), between Sam Martin (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • December 29th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of January 1, 2018 (the “Effective Date”), between Margo Heath-Chiozzi, M.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 3rd, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of October 3, 2017, between Margo Heath-Chiozzi (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 5th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of July 1, 2017 (the “Effective Date”), between Sam Martin (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2017 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on June 15, 2017 (the “Effective Date”), between Sarah Cavanuagh (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 5th, 2016 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 29th of November, 2016 (the “Effective Date”), between Theresa LaVallee (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 11th, 2016 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 10th day of August, 2016, and effective as of August 10, 2016 (the “Effective Date”), between Elizabeth Crowley (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 10th, 2015 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of July, 2015 (the “Effective Date”), between Richard Wright (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2012 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of January, 2013 (the “Effective Date”), between Ronald A. Pepin, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2012 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of January, 2013 (the “Effective Date”), between Tibor Keler, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2012 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of January, 2013 (the “Effective Date”), between Anthony S. Marucci (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2012 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of January, 2013 (the “Effective Date”), between Thomas Davis, M.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • December 21st, 2012 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of January, 2013 (the “Effective Date”), between Avery W. Catlin (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • July 6th, 2011 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 1st day of July, 2011 (the “Effective Date”), between Ronald A. Pepin, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • January 8th, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6 day of January, 2009 (the “Effective Date”), between Tibor Keler, Ph.D. (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 8th, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of January, 2009, and amends, restates and integrates in its entirety the Employment Agreement entered into on July 21, 2008 (the “Effective Date”), between Anthony S. Marucci (the “Executive”) and CELLDEX THERAPEUTICS, INC. (f/k/a AVANT IMMUNOTHERAPEUTICS, INC.), a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
EMPLOYMENT AGREEMENTEmployment Agreement • January 8th, 2009 • Celldex Therapeutics, Inc. • In vitro & in vivo diagnostic substances • Delaware
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6 day of January, 2009 (the “Effective Date”), between Thomas Davis, MD (the “Executive”) and CELLDEX THERAPEUTICS, INC., a Delaware corporation (the “Company”) (collectively, the Executive and the Company shall be referred to as the “Parties”). In consideration of the mutual promises and agreements contained herein, the Parties agree as follows:
